Research News

  • Dixon Named 2022-23 University Scholar
    Anne Dixon, M.A., BM BCh, professor of medicine, has been named one of four 2022-2023 University Scholars.
  • Inaugural Research Week Features Larner Faculty and Trainee Investigation & Innovation
    In celebration of its standing as a top 100 public research university, the University of Vermont held its first “Research Week” April 18 to 22 to showcase the work of faculty, student and trainee investigators. A number of Larner College of Medicine faculty and trainees received recognition and delivered presentations during the week's events.
  • Improving Access to Pediatric Clinical Trials in Vermont
    Infants and children living in rural states are less likely than those living in other states to have a chance to enroll in clinical research, especially clinical trials. Underserved and minority children are particularly underrepresented. The University of Vermont is one of 18 sites in a state-of-the-art pediatric clinical research network to improve access to clinical trials for children in rural and underserved areas. Together, the sites constitute the Environmental Influences on Child Health Outcomes (ECHO) Institutional Development Awards (IDeA) States Pediatric Clinical Trials Network (ISPCTN).
  • Kirkpatrick Presents University Scholar Lecture on Combatting Global Infectious Diseases
    University of Vermont Chair of Microbiology and Molecular Genetics Beth Kirkpatrick, M.D., will present her 2021-22 University Scholar lecture on "Combatting Global Infectious Diseases: Vaccines and Human Models," on Monday, April 4, 2022.
  • Study Finds Exposure to Phthalates May Increase Children's Cancer Risk
    In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the “everywhere chemical,” to higher incidence of specific childhood cancers.
  • Bivona Creates an Open-Source Mouse Wheel
    Like many inventions, the LOST-Wheel was born out of necessity and, jokes Bivona, out of spite. In his final years as a Cellular, Molecular, and Biomedical Sciences graduate student, Bivona worked on a grant-funded project in the laboratory of UVM Larner College of Medicine Professor of Medicine Matthew Poynter, Ph.D. The project, says Poynter, aims to determine the contribution of skeletal muscle contractile muscle cells (myocytes) to local and systemic inflammation and the potential benefits of exercise to diminish overexuberant or protracted inflammation. The work relies heavily on the study of mouse models after they exercise either on rodent treadmills (yes, they make treadmills for rodents) or on small circular machines commonly called mouse wheels.
  • CVRI Viridis Montis Challenge Highlights Early-Career Researchers
    Cardiac remodeling, chronic kidney disease, brain cell energy generation, hypertension and stroke risk, and socioeconomic status and cardiac rehabilitation outcomes, were the topics presented at the Cardiovascular Research Institute of Vermont’s annual Viridis Montis Early Career Investigator Challenge on February 2, 2022.
  • UVM Cancer Researcher Frances Carr Elected AAAS Fellow
    Frances Carr, Ph.D., professor of pharmacology at the Larner College of Medicine at the University of Vermont and UVM Cancer Center member, has been elected to the American Association for the Advancement of Science Fellows Class of 2021.
  • Bruce and Despres' Study Sheds Light on COVID-19 Variants' Infectivity
    In a new study in the journal PNAS, a team of University of Vermont and University of Washington scientists discovered that – based on clinical samples from infected individuals – the Delta variant had a higher infectivity than the Alpha variant of COVID-19.
  • Summer Student Research Program Trains Next Generation of Cancer Scientists
    The UVM Cancer Center Summer Student Fellowships in Cancer Research provide $3,000 stipends to graduate and medical students for cancer-related research projects, overseen by senior faculty members affiliated with the center.